Abstract
In cancer patients, the management of nausea and vomiting that is not directly related to treatment is challenging. Much current practice is based on expert opinion and anecdote. Fortunately, over recent years, a number of quality trials have been undertaken to strengthen the evidence base that guides the care of our patients with these distressing symptoms. Much is still unknown however. In this article, we present the latest literature that addresses some of the outstanding issues.
Keywords:
Cancer; Nausea; Palliative care; Vomiting.
MeSH terms
-
Analgesics, Opioid / pharmacology
-
Analgesics, Opioid / therapeutic use
-
Antiemetics / pharmacology
-
Antiemetics / therapeutic use
-
Biomarkers
-
Disease Management
-
Disease Susceptibility*
-
Drug Therapy, Combination
-
Humans
-
Intestinal Obstruction / etiology
-
Medical Marijuana / pharmacology
-
Medical Marijuana / therapeutic use
-
Molecular Targeted Therapy
-
Nausea / diagnosis
-
Nausea / etiology*
-
Nausea / metabolism
-
Nausea / therapy*
-
Neoplasms / complications*
-
Prognosis
-
Serotonin Antagonists / pharmacology
-
Serotonin Antagonists / therapeutic use
-
Treatment Outcome
-
Vomiting / diagnosis
-
Vomiting / etiology*
-
Vomiting / metabolism
-
Vomiting / therapy*
Substances
-
Analgesics, Opioid
-
Antiemetics
-
Biomarkers
-
Medical Marijuana
-
Serotonin Antagonists